Delivery Order SPE2DR25D2104-SPE2DR26F3NYA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,567.90 on August 6, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,078.36. This firm fixed-price delivery order, which is not set aside for any specific business category, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is identified as...
- The Defense Logistics Agency awarded a delivery order valued at $2,818.29 to AmerisourceBergen Drug Corp for the supply of Janumet 50-500 mg tablets (180-count package) on November 5, 2025, with completion scheduled for November 6, 2025. This non-set-aside, competitively awarded contract operates under a firm fixed price structure and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) at a ceiling value of $3,324.60. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is set for ultimate completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $6,130.28 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The contract performs at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,605.05 on October 28, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of October 29, 2025, and represents a routine pharmaceutical procurement supporting federal medical supply needs. The place of performance is the vendor's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,101.53 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count) on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed-price contract with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $23,089.23 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units). This firm fixed price, non-set-aside contract was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. As a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $3,220.94 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price contract with an ultimate completion date of September 24, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $2,384.55 to AmerisourceBergen Drug Corp for 1,000 tablets of Janumet 50-1,000 mg on November 4, 2025, with completion scheduled for November 5, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement for pharmaceutical supply to support federal medical procurement needs. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NYADelivery Order
The Defense Logistics Agency awarded a $2,606.15 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count). This firm fixed-price contract, which is non-set-aside and competitively awarded, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 13, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency, supplying comprehensive ranges of pharmaceutical products and medical supplies across multiple therapeutic domains. The SPE2DX prime vendor contract serves as a flexible vehicle enabling AmerisourceBergen to deliver medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency operations and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 11/12/25 |